![]() He joined the Women's Malignancies Branch in 2022. He then returned to NCI first joining the Investigational Drug Branch of CTEP and then the Lymphoid Malignancies Branch (formerly, Metabolism Branch) of CCR where the focus of his research was IL-15 and other immunotherapeutics. Conlon subsequently returned to Rush University Section of Medical Oncology to continue his clinical and translational immunotherapy efforts. He left NCI to become a medical officer at the Center for Biologics Evaluation and Research at the FDA, and later a clinical director at the Genetics Institute in Cambridge, Massachusetts. Conlon completed a fellowship in medical oncology at NCI, where he remained to continue his translational research in the Biological Response Modifiers Program. Luke's Medical Center and serving as chief medical resident, Dr. Add/Change Agent: Select Agent No agent 22ft Aaji Emile Abdat Adam Abderrahim Ahmed Abderrahim Dali Abduljalil Yusuf Abdullah Sadiq Abdullah Yousuf Abdur-Rahim Muhammad Aberdeen Barry Abraham. After completing his residency in internal medicine at Rush-Presbyterian-St. Team: Leeuwarden (2022-2023) NBA Draft Eligible: 2024. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |